Drug Shortage Report for PROQUAD

Last updated on 2023-01-06 History
Report ID 177230
Drug Identification Number 02399229
Brand name PROQUAD
Common or Proper name measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) RUBELLA VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED
Strength(s) 3.00Log10 TCID50 4.30Log10 TCID50 3.00Log10 TCID50 3.99Log10 PFU
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10 X 1 DOSE VIAL
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-01-07
Actual start date
Estimated end date 2023-01-31
Actual end date 2023-01-06
Shortage status Avoided shortage
Updated date 2023-01-06
Company comments Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-01-06 French Compare
v11 2023-01-06 English Compare
v10 2023-01-06 French Compare
v9 2023-01-06 English Compare
v8 2023-01-06 English Compare
v7 2022-12-15 French Compare
v6 2022-12-15 English Compare
v5 2022-12-09 French Compare
v4 2022-12-09 English Compare
v3 2022-12-07 French Compare
v2 2022-12-07 French Compare
v1 2022-12-07 English Compare

Showing 1 to 12 of 12